國家衛生研究院 NHRI:Item 3990099045/3227
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 855628      在线人数 : 1275
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/3227


    题名: The Asian Vaccine Industry: Opportunities and challenges
    作者: Chong, P
    贡献者: Vaccine Research and Development Center
    摘要: Asian governments are looking to Biotechnology to accelerate their food supplies and healthcare improvement, and some are even thinking about the economic growth through manufacturing valuable biological products. Companies and government agencies in Asia have been closing the gaps in regulatory compliance in manufacturing biologics in the last few years. However, countries such as China, Korea and India still lag behind in vaccine R&D and production techniques due to a lack of financial support and technology transfers from foreign companies. Emerging infectious diseases (pandemic avian influenza and global shortage of flu vaccines supply) have raised new challenges. They have changed the landscape of the vaccine industry. The processes involved in research to product launch normally take 7 to 13 years to go through multi-stage R&D and still have a low success rate. Today, novel technologies are being used and investigated for new vaccine developments.
    日期: 2008
    關聯: Pharma Focus Asia. 2008;6:42-46.
    Link to: https://www.pharmafocusasia.com/research-development/asian-vaccine-industry
    显示于类别:[莊再成] 期刊論文

    文件中的档案:

    没有与此文件相关的档案.



    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈